RNA dysregulation in neurodegenerative diseases

Y Li, S Sun - The EMBO Journal, 2025 - embopress.org
Dysregulation of RNA processing has in recent years emerged as a significant contributor to
neurodegeneration. The diverse mechanisms and molecular functions underlying RNA …

Amyotrophic lateral sclerosis represents corticomotoneuronal system failure

A Eisen, S Vucic, MC Kiernan - Muscle & Nerve, 2024 - Wiley Online Library
Several decades have passed since the anterograde corticomotoneuronal hypothesis for
amyotrophic lateral sclerosis (ALS) was proposed. The intervening years have witnessed its …

TDP‐43 Cryptic RNAs in Perry Syndrome: Differences across Brain Regions and TDP‐43 Proteinopathies

SR Pickles, J Gonzalez Bejarano… - Movement …, 2025 - Wiley Online Library
Background Perry syndrome (PS) is a rare and fatal hereditary autosomal dominant
neurodegenerative disorder caused by mutations in dynactin (DCTN1). PS brains …

A phase Ib/IIa randomized trial of Enoxacin in patients with ALS

I Magen, HM Kaneb, M Masnata, N Pulimood, A Emde… - medRxiv, 2024 - medrxiv.org
Abstract Background and Objectives The RNAse III DICER is essential for miRNA
biogenesis. DICER activity is downregulated in sporadic and genetic forms of ALS …

[PDF][PDF] Analysis of the therapeutic strategies used to treat Amyotrophic Lateral Sclerosis caused by TDP-43 aggregation and/or mislocalization

S Sar - Journal of High School Science, 2024 - jhss.scholasticahq.com
Amyotrophic Lateral Sclerosis (ALS), a fatal neurodegenerative disorder that impairs motor
functions, affects 1 in 50,000 people in the world, and has an insignificant hereditary …